134 related articles for article (PubMed ID: 3019818)
1. A new method to assay des-gamma-carboxyprothrombin. Results obtained in 75 cases of hepatocellular carcinoma.
Soulier JP; Gozin D; Lefrere JJ
Gastroenterology; 1986 Nov; 91(5):1258-62. PubMed ID: 3019818
[TBL] [Abstract][Full Text] [Related]
2. [A new method of functional assay of des-gamma-carboxyprothrombin using staphylocoagulase. Application to the diagnosis of hepatocellular carcinoma].
Soulier JP; Gozin D; Lefrère JJ
Presse Med; 1985 Nov; 14(40):2049-52. PubMed ID: 3001686
[TBL] [Abstract][Full Text] [Related]
3. Assay of des-gamma-carboxyprothrombin using staphylocoagulase. Application to the diagnosis of cellular hepatocarcinoma.
Soulier JP; Gozin D; Lefrère JJ
Haematologia (Budap); 1986; 19(1):3-12. PubMed ID: 2424813
[TBL] [Abstract][Full Text] [Related]
4. Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma.
Tsai SL; Huang GT; Yang PM; Sheu JC; Sung JL; Chen DS
Hepatology; 1990 Mar; 11(3):481-8. PubMed ID: 2155866
[TBL] [Abstract][Full Text] [Related]
5. Specificity of increased des-gamma-carboxyprothrombin in hepatocellular carcinoma after vitamin K1 injection.
Lefrère JJ; Gozin D; Soulier JP; Bettan L; Mavier P; Dhumeaux D; Guillaumont M; Leclercq M
J Hepatol; 1987 Aug; 5(1):27-9. PubMed ID: 2821104
[TBL] [Abstract][Full Text] [Related]
6. Application of des-gamma-carboxy prothrombin as a complementary tumor marker with alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Ho CH; Lee SD; Chang HT; Wu JC; Tsai YT; Lo KJ
Scand J Gastroenterol; 1989 Jan; 24(1):47-52. PubMed ID: 2467347
[TBL] [Abstract][Full Text] [Related]
7. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
[TBL] [Abstract][Full Text] [Related]
8. Serum des-gamma-carboxyprothrombin concentration determined by the avidin-biotin complex method in small hepatocellular carcinomas.
Saitoh S; Ikeda K; Koida I; Tsubota A; Arase Y; Chayama K; Kumada H
Cancer; 1994 Dec; 74(11):2918-23. PubMed ID: 7525036
[TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of des-gamma-carboxy prothrombin assay in early diagnosis of hepatocellular carcinoma.
Fujiyama S; Izuno K; Gohshi K; Shibata J; Sato T
Dig Dis Sci; 1991 Dec; 36(12):1787-92. PubMed ID: 1721019
[TBL] [Abstract][Full Text] [Related]
10. A comparison between des-gamma-carboxy prothrombin and alpha-fetoprotein as markers of hepatocellular carcinoma in southern African blacks.
King MA; Kew MC; Kuyl JM; Atkinson PM
J Gastroenterol Hepatol; 1989; 4(1):17-24. PubMed ID: 2485005
[TBL] [Abstract][Full Text] [Related]
11. Plasma abnormal prothrombin (des-gamma-carboxy prothrombin) as a marker of hepatocellular carcinoma.
Fujiyama S; Morishita T; Hashiguchi O; Sato T
Cancer; 1988 Apr; 61(8):1621-8. PubMed ID: 2450634
[TBL] [Abstract][Full Text] [Related]
12. Production of abnormal prothrombin (des-gamma-carboxy prothrombin) by hepatocellular carcinoma. A clinical and experimental study.
Okuda H; Obata H; Nakanishi T; Furukawa R; Hashimoto E
J Hepatol; 1987 Jun; 4(3):357-63. PubMed ID: 3036940
[TBL] [Abstract][Full Text] [Related]
13. Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review.
Weitz IC; Liebman HA
Hepatology; 1993 Oct; 18(4):990-7. PubMed ID: 8406374
[TBL] [Abstract][Full Text] [Related]
14. Coagulation assays as diagnostic markers of hepatocellular carcinoma.
Lefrère JJ; Conard J; Mavier P; Bettan L; Beaugrand M; Gozin D; Lerable J; Dhumeaux D; Samama M
Thromb Haemost; 1988 Dec; 60(3):468-70. PubMed ID: 2467402
[TBL] [Abstract][Full Text] [Related]
15. Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.
Nakao A; Virji A; Iwaki Y; Carr B; Iwatsuki S; Starzl E
Hepatogastroenterology; 1991 Oct; 38(5):450-3. PubMed ID: 1722483
[TBL] [Abstract][Full Text] [Related]
16. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
17. The usefulness of determining des-gamma-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma.
Mita Y; Aoyagi Y; Yanagi M; Suda T; Suzuki Y; Asakura H
Cancer; 1998 May; 82(9):1643-8. PubMed ID: 9576283
[TBL] [Abstract][Full Text] [Related]
18. Distribution of the heterogeneity of des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma.
Uehara S; Gotoh K; Handa H; Tomita H; Senshuu M
J Gastroenterol Hepatol; 2005 Oct; 20(10):1545-52. PubMed ID: 16174072
[TBL] [Abstract][Full Text] [Related]
19. Determination of serum des-gamma-carboxy prothrombin levels in patients with small-sized hepatocellular carcinoma: comparison of the conventional enzyme immunoassay and two modified methods.
Nomura F; Ishijima M; Horikoshi A; Nakai T; Ohnishi K
Am J Gastroenterol; 1996 Jul; 91(7):1380-3. PubMed ID: 8677999
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of simultaneous determination of alpha-fetoprotein and des-gamma-carboxy prothrombin in hepatocellular carcinoma.
Nakao A; Taniguchi K; Inoue S; Harada A; Nonami T; Watanabe K; Takagi H
Semin Surg Oncol; 1996; 12(3):160-3. PubMed ID: 8727604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
